SAN MATEO, Calif., April 27, 2012 (GLOBE NEWSWIRE) -- NeurogesX, Inc. (Nasdaq:NGSX), a specialty pharmaceutical company focused on developing and commercializing a portfolio of novel non-opioid, pain management therapies, today announced it will hold a conference call on Thursday, May 3, 2012, at 4:30 p.m. ET (1:30 p.m. PT) to report results for its first quarter ended March 31, 2012.
